TELA Bio - TELA Company Value to Revenue Ratio

Public company logo of TELA Bio Corp (TELA)

The enterprise value-to-revenue ratio allows for an assessment of market expectations for TELA Bio, Inc. (TELA), whose revenue is based on the sale of innovative OviTex grafts. TELA Bio, Inc. (TELA) is expanding its presence in plastic surgery by offering biocompatible implants as an alternative to synthetics. Stable demand and demographics protect performance metrics from macroeconomic shocks, with the indicator settling at 857.12, excluding the impact of debt.

TELA TELA Bio: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

TELA (telabio.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental valuation:TELA Bio Inc. TELA
Mass-produced product of TELA Bio, Inc.

This indicator measures the enterprise value of the business, accounting for net debt per unit of revenue, allowing for an assessment of the asset's real price regardless of capital structure. By analyzing the EV/Sales ratio, an investor can gauge valuation sensitivity to growth rates, which for TELA Bio, Inc. (TELA) reflects the transition from the R&D stage to the commercial scaling of OviTex implants on a stable technological plateau.

Competitor analysis for TELA Bio, Inc.

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)